Moreover, translational reprogramming, especially with regard to upstream initiation sites, appears to represent an important cancer driver (30), and understanding how the translation of cancer-relevant DENR targets is regulated may thus lead to important insights of diagnostic or therapeutic value. This evidence concerns the gene DENR and cancer.